Champions Oncology, Inc. (CSBR)

Market Cap	91.62M
Revenue (ttm)	56.94M
Net Income (ttm)	4.70M
Shares Out	13.78M
EPS (ttm)	0.33
PE Ratio	20.15
Forward PE	30.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,976
Open	6.75
Previous Close	7.75
Day's Range	6.65 - 7.70
52-Week Range	3.60 - 11.99
Beta	0.44
Analysts	Strong Buy
Price Target	12.00 (+80.45%)
Earnings Date	Jul 23, 2025

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Mar 25, 1986
• Employees: 213
• Stock Exchange: NASDAQ
• Ticker Symbol: CSBR
• Website: https://www.championsoncology.com

Analyst Summary

According to one analyst, the rating for CSBR stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target

$12.0

(80.45% upside)

Analyst Consensus: Strong Buy